Drug parent form, release of aromatics inhibitors and gene management for endometrial therapy

摘要

The endocrine therapy content of the invention is to provide a drug paternalistic form (management system) for controlling the release of aromatic inhibitors (AI). The daily release rate shall not cause the ovary to be stimulated due to the negative reduction of the axis. Hypnosis of the ovary (causes lymphatic secretion and stimulates ovarian cell growth)And a genetic gesture with a daily release rate lower than the dose of controlled ovulation, which uses contraceptive measures based on local actions, such as reducing the concentration and thickness of cervical mucus to prevent sperm from rising, Effects on endocrine and tubal dynamics to avoid egg implantation and transport).